Cited In for PMID: 35507245

Year	Number of Results
2022	3
2023	3
2024	4
2025	2

1

Molitch ME. Molitch ME. Pituitary. 2022 Oct;25(5):733-736. doi: 10.1007/s11102-022-01227-x. Epub 2022 May 4. Pituitary. 2022. PMID: 35507245 Review.

2

Current and Emerging Pharmacological Therapies for Cushing's Disease.

Divaris E, Kostopoulos G, Efstathiadou ZA. Divaris E, et al. Curr Pharm Des. 2024;30(10):757-777. doi: 10.2174/0113816128290025240216110928. Curr Pharm Des. 2024. PMID: 38424426 Review.

3

Pseudohypoadrenalism, a subclinical cortisol metabolism disorder in hyperuricemia.

Bao R, Chen B, Pan J, Wang A, Yu H, Chen Q, Zhang Y, Wang T. Bao R, et al. Front Endocrinol (Lausanne). 2023 Nov 16;14:1279205. doi: 10.3389/fendo.2023.1279205. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38034015 Free PMC article.

4

Update on the Role of Glucocorticoid Signaling in Osteoblasts and Bone Marrow Adipocytes During Aging.

Bensreti H, Alhamad DW, Gonzalez AM, Pizarro-Mondesir M, Bollag WB, Isales CM, McGee-Lawrence ME. Bensreti H, et al. Curr Osteoporos Rep. 2023 Feb;21(1):32-44. doi: 10.1007/s11914-022-00772-5. Epub 2022 Dec 24. Curr Osteoporos Rep. 2023. PMID: 36564571 Free PMC article. Review.

5

A TBX2-driven signaling switch from androgen receptor to glucocorticoid receptor confers therapeutic resistance in prostate cancer.

Dutta S, Khedmatgozar H, Patel GK, Latour D, Welsh J, Mustafi M, Mitrofanova A, Tripathi M, Nandana S. Dutta S, et al. Oncogene. 2025 Apr;44(13):877-892. doi: 10.1038/s41388-024-03252-5. Epub 2024 Dec 20. Oncogene. 2025. PMID: 39702503 Free PMC article.

6

Special issue: Cushing's disease update.

Fleseriu M. Fleseriu M. Pituitary. 2022 Oct;25(5):687-688. doi: 10.1007/s11102-022-01271-7. Epub 2022 Aug 24. Pituitary. 2022. PMID: 36001219 No abstract available.

7

New Trends in Treating Cushing's Disease.

Violetis O, Alexandraki KI. Violetis O, et al. touchREV Endocrinol. 2024 Oct;20(2):10-15. doi: 10.17925/EE.2024.20.2.3. Epub 2024 Apr 8. touchREV Endocrinol. 2024. PMID: 39526050 Free PMC article.

8

Characteristics of adverse drug reactions and risk management strategies for methylprednisolone sodium succinate in the treatment of idiopathic sudden sensorineural hearing loss: a clinical study of 1026 patients.

Wu T, Tang Y, Yan S, Meng J, He S, Meng W. Wu T, et al. Front Med (Lausanne). 2025 Jun 11;12:1589531. doi: 10.3389/fmed.2025.1589531. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40568206 Free PMC article.

9

Iatrogenic adrenal insufficiency in adults.

Martin-Grace J, Tomkins M, O'Reilly MW, Sherlock M. Martin-Grace J, et al. Nat Rev Endocrinol. 2024 Apr;20(4):209-227. doi: 10.1038/s41574-023-00929-x. Epub 2024 Jan 25. Nat Rev Endocrinol. 2024. PMID: 38272995 Review.

10

Current and Emerging Treatment Options for Uterine Fibroids.

Ali M, Ciebiera M, Wlodarczyk M, Alkhrait S, Maajid E, Yang Q, Hsia SM, Al-Hendy A. Ali M, et al. Drugs. 2023 Dec;83(18):1649-1675. doi: 10.1007/s40265-023-01958-6. Epub 2023 Nov 3. Drugs. 2023. PMID: 37922098 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Results by year

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Cited In for PMID: 35507245

10 results

Results by year